CEO Corner

From Clinical To Market: Managing Pharma's Most Challenging Transition

For drugmakers, approval is just the opening bell; the challenge is turning scientific success into commercial traction, writes ARS Pharmaceutical CEO Richard Lowenthal.

Why The Best Biotech Leaders Take It Personally

Personal investment isn’t a liability in biotech leadership, but rather, a competitive advantage, writes Lisa Ricciardi, CEO of Cognition Therapeutics.

How The New Biotech Market Is Redefining Leadership

The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and investor relations are paramount, writes Jeff Walsh, CEO of nChroma Bio.

Building Biotech Champions: Cultivating Breakthroughs In A Dynamic Field

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.

Balanced Disruption: Leading Change In A Family-Owned Pharma Company

Driving growth in a family-owned pharma company requires a balance of progress and preservation, writes Merz Therapeutics CEO Stefan König.

Winning With The Right Marbles: The Future of Generics

After decades of racing to the bottom on pricing, a revolution is coming to the U.S. generics market, writes Yaral Pharma CEO Stephen Beckman.

Planning For Perseverance

AC Immune SA cofounder and CEO Andrea Pfeifer offers lessons in strategy and resilience for building and maintaining a drug development company amid internal and external ups and downs.

Leading Through Biotech's Perfect Storm: Lessons From The Front Lines

Memo Therapeutics CEO Erik van den Berg reflects on the strategies and skills needed to build company resilience and navigate successfully through challenging external circumstances.

How To Lead a Company That's Disrupting An Industry

Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.

From Bike Mechanic To Surgeon To CEO

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, surgeon, and biopharmaceutical leader.